EN
繁
简
EN
Home
About Us
Company Info
Company Address
Careers
Investor Information
Board of Directors and Committees
Announcement
Notice
Corporate Governance
Scroll Down
Our Services
Personal Investment
Internet Trading
Stock
HK Stocks
Stock Margin
IPO
SH-HK / SZ-HK Stock Connect
Global Market
Futures
Options
Brokerage Services
Discretionary Service
Investor Corner
Wealth Management
Our Dedicated Service
Funds
Bonds
Structured Product
Wealth Planning
Corporate Insurance
Investment Banking
SC Private
Scroll Down
Professional Research
Research Report
Power Pick
Market Express
Market Research
SC Knowledge
Chairman's View
Ngor's Pick
Insurance Express
Politic
SC Classroom
Scroll Down
Customer Service
Exclusive Offer
Charges
HK Stocks
IPO
Stock Margin
SH-HK / SZ-HK Stock Connect
Global Market
HK Futures
Stock Option
Index Option
Funds
Bonds
Structured Product
Deposit & Withdrawal
HK Stocks
Shanghai-HK Stock Connect / Shenzhen-HK Stock Connect
US Stocks
Global Securities
Futures / Options
Technical Support
Download Center
Securities Trading System User Mannual
Futures Trading System User Mannual
Forms Download
Individual Account
Corporate Account
Other
FAQ
Account Opening
Fund Deposit and Withdrawal
Trading Transaction
Real Time Quote System
Scroll Down
Contact Us
Login
Account Opening
Login
Account Opening
Securities
Securities(南華交易寶)
Login
Login
Home
About Us
Company Info
Company Address
Careers
Investor Information
Board of Directors and Committees
Announcement
Notice
Corporate Governance
Our Services
Personal Investment
Internet Trading-Stock-HK Stocks
Internet Trading-Stock-Stock Margin
Internet Trading-Stock-IPO
Internet Trading-Stock-SH-HK / SZ-HK Stock Connect
Internet Trading-Stock-Global Market
Internet Trading-Futures
Internet Trading-Options
Brokerage Services
Discretionary Service
Investor Corner
Wealth Management
Our Dedicated Service
Funds
Bonds
Structured Product
Wealth Planning
Corporate Insurance
Investment Banking
One-stop IPO sponsorship for companies preparing to be listed on the HKEx
Mergers and acquisitions (M&A)
Financial advisory (Financial Advisor/ Independent Financial Advisor)
Regulatory compliance advisory
Pre-IPO financing and advisory
Fund-raising for listed companies & unlisted growing companies
Due diligence
Business valuation & financial modelling
SC Private
Professional Research
Research Report
Power Pick
Market Express
Market Research
SC Knowledge
Chairman's View
Ngor's Pick
Insurance Express
Politic
SC Classroom
Customer Service
Exclusive Offer
Charges
Deposit & Withdrawal
Real Time Quote System
Technical Support
Forms Download
FAQ
Contact Us
Home
Professional Research
Research Report
Market Research
南華金融 Sctrade.com 企業要聞 (08月29日) |中生製藥抗癌藥增 恒大負債高
2019.08.29 Thursday PM3:58
中國生物製藥(1177 HK)
抗腫瘤藥增長強勁,成主要收入來源之一
中國恒大(3333 HK)
核心業務利潤跌,凈負債率152%
蒙牛乳業(2319 HK)
EBITDA利潤率上升
Previous
Next